LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
126 hedge funds and large institutions have $199M invested in Lumos Pharma, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 32 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
22% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 41
Holders
126
Holding in Top 10
–
Calls
$15.2M
Puts
$4.89M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$10.8M | |
| 3 | +$7.04M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$5.16M |
| 5 |
PA
Perceptive Advisors
New York
|
+$4.58M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$8.03M | |
| 3 | -$3.26M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.03M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.72M |